Categories: Wire Stories

Lianhua Qingwen Launched in the Philippines Scientific Usage Makes Better Effect

SHIJIAZHUANG CITY, China–(BUSINESS WIRE)–Lianhua Qingwen Capsules, an innovative patent traditional Chinese medicine, is produced by China�s Yiling Pharmaceutical under the guidance of TCM Collateral Disease Theory. It has been widely used for symptoms caused by mild and moderate COVID-19, such as fever, cough and fatigue, been recommended by Diagnosis and Treatment Protocol for COVID-19 (Trial Version 4-8), published jointly by China’s National Health Commission and National Administration of TCM. On November 23, Lianhua Qingwen was launched in the Philippines and many Philippine consumers have rushed to purchase this medicine.

Is there any notice for taking Lianhua Qingwen Capsules? How to take it to realize the maximal efficacy? Correct way is to take it orally, 3 capsules 1 time, 3 times a day. Keep taking it regularly can treat influenza caused by toxic heat attacking lung with symptoms of fever, aversion to cold, muscular soreness, nasal obstruction & running nose, cough, headache, dry & sore throat, reddish tongue, yellow tongue coating or oily tongue coating, etc.

While using Lianhua Qingwen, please stop smoking, drinking, and don’t eat spicy, raw, cold and oily foods. Patients with hypertension or heart disease should use with caution, patients with chronic disease such as diabetes, liver disease, kidney disease should take medicine under doctors’ direction. Children, pregnant women, nursing mother, senile and infirm patients or those with week spleen should take it under doctors’ direction. Also interaction may appear if administered accompanied with other medicine, consult with doctors or pharmacists for details.

The registration number of Lianhua Qingwen Capsules in the Philippines is THPR-50 and the product category is traditional herbal drugs. Now this medicine is available in Mercury Drug, Southstar Drug and Watson.

Contacts

First Name: Li

Last Name: Kristy

E-mail:kristyli@chuhaimedia.com.cn
Phone No.: +86 85962566

Alex

Recent Posts

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

16 hours ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

17 hours ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

19 hours ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

19 hours ago

Wipro Appoints Sanjeev Jain as Chief Operating Officer

EAST BRUNSWICK, N.J. & BENGALURU, India--(BUSINESS WIRE)--$WIPRO #AIprinciples--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO),…

19 hours ago

Cleaver-Brooks Acquired by Miura Co., Ltd.

THOMASVILLE, Ga.--(BUSINESS WIRE)--Cleaver-Brooks announces that it has been acquired by Miura Co., Ltd., a leading…

19 hours ago